As a part of its overall Value Assessment Initiative, the PhRMA Foundation has established the Value Assessment Challenge Awards to help promote leadership and innovative approaches to determining value in health care.
A key challenge in accounting for patient-centered outcomes and impacts in value assessment is the lack of existing data (e.g., clinical trials, observational data sources) and data collection tools (e.g., prospective EMR data collection) to measure outcomes important to patients.
We invite submissions based on bold and creative ideas to advance methods and process associated with value assessment (and/or value elements). The PhRMA Foundation seeks papers that describe solutions to one or both of the following questions. (The total response must not exceed 3,000 words excluding title, figures and bibliography.)
Deadline: March 1, 2022
Award opportunities are open to all individuals and organizations with a specialization in health economics, outcomes research, clinical sciences, health care evaluation, public health, health equity or related disciplines.
Eligible applicants (or collaborators) should be affiliated with an academic institution in the United States, U.S. patient group or organization focused on improving health care in the U.S.
Collaboration across stakeholder groups and fields of discipline is encouraged.
The Value Assessment Initiative encourages new researchers to apply for funding. Researchers and collaborators who have received a Value Assessment Award or funding from the PhRMA Foundation in 2020, 2021 or 2022 are not eligible to apply.
Recipients of Challenge Awards may be asked to present their winning papers at a public forum. Awards will be given in the following amounts.
